High expression of Mcl‐1L via the MEK‐ERK‐phospho‐STAT3 (Ser727) pathway protects melanocytes and melanoma from UVB‐induced apoptosis

Authors:

Abstract
Ultraviolet (UV) B is a major factor in melanomagenesis. This fact is linked to the resistance of melanocytes to UVB‐induced apoptosis. In this study, we characterized the involvement of Mcl‐1L in the regulation of UVB‐induced apoptosis in melanocytes and in melanoma cells. In melanocytes, apoptosis was not evident at 24 h after UVB irradiation. The Mcl‐1L expression increased after UVB irradiation, and the high Mcl‐1L expression continued for at least 24 h. This UVB‐dependent increase in Mcl‐1L was mediated by the MEK‐ERK‐pS‐STAT3 (STAT3 phosphorylated at Ser727) pathway. The Ser727 phosphorylation facilitated nuclear localization of STAT3. In melanoma cells, the expression levels of Mcl‐1L varied depending on the cell line. WM39 melanoma cells expressed high levels of Mcl‐1L via the MEK‐ERK‐pS‐STAT3 pathway and were resistant to UVB‐induced apoptosis without up‐regulation of Mcl‐1L. In melanocytes and in WM39 cells, transfection with Mcl‐1 siRNA promoted UVB‐induced apoptosis. Immunohistochemical studies showed that melanoma cells in in situ lesions expressed high amounts of Mcl‐1L. These results indicate that the high expression of Mcl‐1L mediated by the MEK‐ERK‐pS‐STAT3 pathway protects melanocytes and melanoma cells from UVB‐induced apoptosis.
Funding Information
  • Ministry of Education, Culture, Sports, Science, and Technology (26461692 and 24791155)

This publication has 38 references indexed in Scilit: